Crystallography Open Database

Result: there are 4213 entries in the selection

Switch to the old layout of the page

Download all results as: list of COD numbers | list of CIF URLs | data in CSV format | archive of CIF files (ZIP)

Searching volume of publication is 4

Blue left arrow Blue left arrow First | Blue left arrow Previous 50 | of 85 | Next 50 Blue right arrow | Last Blue right arrow Blue right arrow | Display 5 20 50 100 200 300 500 1000 entries per page

COD ID Blue up arrow Links Formula Up arrow Space group Up arrow Cell parameters Cell volume Up arrow Bibliography
1100120 CIFC2 Ba2 Co F2 O6P b c a6.6226; 11.494; 9.021
90; 90; 90
686.68Ben Ali, A.; Maisonneuve, V.; Kodjikian, S.; Smiri, L. S.; Leblanc, M.
Synthesis, crystal structure and magnetic properties of a new fluoride carbonate Ba~2~Co(CO~3~)~2~F~2~
Solid State Sciences, 2002, 4, 503-506
1100121 CIFC Ba F2 Mn O3P 63/m4.912; 4.912; 9.919
90; 90; 120
207.26Ben Ali, A.; Maisonneuve, V.; Smiri, L.S.; Leblanc, M.
Synthesis and crystal structure of Ba Zn (C O3) F2; revision of the structure of Ba Mn (C O3) F2
Solid State Sciences, 2002, 4, 891-894
1100122 CIFC Ba F2 O3 ZnP 63/m4.8523; 4.8523; 9.854
90; 90; 120
200.93Ben Ali, A.; Maisonneuve, V.; Smiri, L.S.; Leblanc, M.
Synthesis and crystal structure of Ba Zn (C O3) F2; revision of the structure of Ba Mn (C O3) F2
Solid State Sciences, 2002, 4, 891-894
1100127 CIFC2 F Na2 O6 YbC 1 2/c 117.44; 6.1003; 11.2366
90; 95.64; 90
1189.67Ben Ali, A.; Maisonneuve, V.; Leblanc, M.
Phase stability regions in the (Na2 C O3) - (Yb F3) - (H2 O) system at 190 C. Crystal structures of two new fluoride carbonates, Na2 Yb (C O3)2 F and Na3 Yb (C O3)2 F2
Solid State Sciences, 2002, 4, 1367-1375
1100128 CIFC2 F2 Na3 O6 YbC 1 c 17.127; 29.816; 6.928
90; 112.56; 90
1359.54Ben Ali, A.; Maisonneuve, V.; Leblanc, M.
Phase stability regions in the (Na2 C O3) - (Yb F3) - (H2 O) system at 190 C. Crystal structures of two new fluoride carbonates, Na2 Yb (C O3)2 F and Na3 Yb (C O3)2 F2
Solid State Sciences, 2002, 4, 1367-1375
1100644 CIFC30 H40 Cl2 N2 O6 Zn2P -18.6024; 10.1643; 10.2254
86.61; 79.601; 69.707
824.81Boche, Gernot; Bosold, Ferdinand; Hermann, Holger; Marsch, Michael; Harms, Klaus; Lohrenz, J. C. W.
Crystal Structure of [2-ZnCl-benzoxazole·2 THF]~2~: The Remarkable Difference between 2-ZnHal- and 2-Li-oxazoles
Chemistry - A European Journal, 1998, 4, 814-817
1101061 CIFC36 H32 Ag2 N26 O14 Pt2C 1 2/c 125.778; 13.521; 13.315
90; 98.06; 90
4595Mohammad Abul Haj; Miguel Quirós; Juan M. Salas; René Faure
Structure of a tetranuclear heterometallic Ag(I)-Pt(II) complex with a triazolopyrimidine derivative.
Inorganic Chemistry Communications, 2001, 4, 254-256
1505170 CIFC40 H38 N8 O4P 1 21/n 15.6367; 32.91; 9.4476
90; 102.342; 90
1712.1Aakeröy, Christer B.; Fasulo, Meg E.; Desper, John
Cocrystal or Salt: Does It Really Matter?
Molecular Pharmaceutics, 2007, 4, 317
1505171 CIFC15 H11 F2 N3 O2P 1 21/n 17.1555; 17.958; 10.9686
90; 101.301; 90
1382.1Aakeröy, Christer B.; Fasulo, Meg E.; Desper, John
Cocrystal or Salt: Does It Really Matter?
Molecular Pharmaceutics, 2007, 4, 317
1505172 CIFC32 H39 N3 O4P -18.8864; 11.9875; 13.7015
99.38; 93.191; 107.556
1364.42Aakeröy, Christer B.; Fasulo, Meg E.; Desper, John
Cocrystal or Salt: Does It Really Matter?
Molecular Pharmaceutics, 2007, 4, 317
1505173 CIFC32 H24 N8 O12P -19.7657; 11.7691; 14.0803
86.227; 74.163; 86.202
1551.53Aakeröy, Christer B.; Fasulo, Meg E.; Desper, John
Cocrystal or Salt: Does It Really Matter?
Molecular Pharmaceutics, 2007, 4, 317
1505174 CIFC13 H16 N4 O4P 1 21/m 18.7478; 6.5361; 12.5842
90; 107.296; 90
686.98Childs, Scott L.; Stahly, G. Patrick; Park, Aeri
The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization State
Molecular Pharmaceutics, 2007, 4, 323
1505175 CIFC14 H15 N4 O5P 1 21/n 16.9183; 25.9086; 7.9749
90; 104.754; 90
1382.32Childs, Scott L.; Stahly, G. Patrick; Park, Aeri
The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization State
Molecular Pharmaceutics, 2007, 4, 323
1505176 CIFC18 H16 N4 O5P 1 21/c 111.814; 31.707; 8.92
90; 98.072; 90
3308.2Childs, Scott L.; Stahly, G. Patrick; Park, Aeri
The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization State
Molecular Pharmaceutics, 2007, 4, 323
1505177 CIFC14 H14 N4 O5P 1 21/c 17.1201; 7.928; 24.763
90; 91.66; 90
1397.2Childs, Scott L.; Stahly, G. Patrick; Park, Aeri
The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization State
Molecular Pharmaceutics, 2007, 4, 323
1505178 CIFC15 H17 N5 O4P 1 21/n 18.7337; 15.3838; 11.5271
90; 99.256; 90
1528.59Childs, Scott L.; Stahly, G. Patrick; Park, Aeri
The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization State
Molecular Pharmaceutics, 2007, 4, 323
1505179 CIFC8 H12 N5 O2P 1 21/c 18.7804; 6.5989; 16.0041
90; 102.292; 90
906.04Childs, Scott L.; Stahly, G. Patrick; Park, Aeri
The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization State
Molecular Pharmaceutics, 2007, 4, 323
1505180 CIFC16 H26 N10 O5P -18.3936; 10.2277; 11.8295
78.839; 77.795; 81.075
966.87Childs, Scott L.; Stahly, G. Patrick; Park, Aeri
The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization State
Molecular Pharmaceutics, 2007, 4, 323
1505181 CIFC17 H13 F3 N2 O6P 1 21/c 18.1434; 20.7559; 10.6511
90; 110.276; 90
1688.73Childs, Scott L.; Stahly, G. Patrick; Park, Aeri
The Salt−Cocrystal Continuum: The Influence of Crystal Structure on Ionization State
Molecular Pharmaceutics, 2007, 4, 323
1505182 CIFC19 H18 N4 O5P 1 21/n 17.6063; 14.042; 16.327
90; 94.03; 90
1739.5Bučar, Dejan-Krešimir; Henry, Rodger F.; Lou, Xiaochun; Duerst, Richard W.; Borchardt, Thomas B.; MacGillivray, Leonard R.; Zhang, Geoff G. Z.
Co-Crystals of Caffeine and Hydroxy-2-naphthoic Acids: Unusual Formation of the Carboxylic Acid Dimer in the Presence of a Heterosynthon
Molecular Pharmaceutics, 2007, 4, 339
1505183 CIFC19 H18 N4 O5P 1 21/c 19.04; 24.42; 8.654
90; 117.015; 90
1702Bučar, Dejan-Krešimir; Henry, Rodger F.; Lou, Xiaochun; Duerst, Richard W.; Borchardt, Thomas B.; MacGillivray, Leonard R.; Zhang, Geoff G. Z.
Co-Crystals of Caffeine and Hydroxy-2-naphthoic Acids: Unusual Formation of the Carboxylic Acid Dimer in the Presence of a Heterosynthon
Molecular Pharmaceutics, 2007, 4, 339
1505184 CIFC19 H18 N4 O5P -18.029; 8.592; 13.996
106.475; 98.162; 104.904
870.3Bučar, Dejan-Krešimir; Henry, Rodger F.; Lou, Xiaochun; Duerst, Richard W.; Borchardt, Thomas B.; MacGillivray, Leonard R.; Zhang, Geoff G. Z.
Co-Crystals of Caffeine and Hydroxy-2-naphthoic Acids: Unusual Formation of the Carboxylic Acid Dimer in the Presence of a Heterosynthon
Molecular Pharmaceutics, 2007, 4, 339
1505185 CIFC13 H18 N4 O10P 1 21/c 117.9217; 6.1766; 15.3751
90; 105.212; 90
1642.32Karki, Shyam; Friščić, Tomislav; Jones, William; Motherwell, W. D. Samuel
Screening for Pharmaceutical Cocrystal Hydrates via Neat and Liquid-Assisted Grinding
Molecular Pharmaceutics, 2007, 4, 347
1505186 CIFC14 H18 N4 O9P -17.3874; 8.3967; 13.5053
91.333; 99.04; 99.588
814.72Karki, Shyam; Friščić, Tomislav; Jones, William; Motherwell, W. D. Samuel
Screening for Pharmaceutical Cocrystal Hydrates via Neat and Liquid-Assisted Grinding
Molecular Pharmaceutics, 2007, 4, 347
1505187 CIFC2 H5 O5.5P n m a11.231; 12.33; 6.9082
90; 90; 90
956.6Wenger, Mazal; Bernstein, Joel
Cocrystal Design Gone Awry? A New Dimorphic Hydrate of Oxalic Acid
Molecular Pharmaceutics, 2007, 4, 355
1505188 CIFC4 H9 O11P -16.337; 7.247; 10.571
94.345; 100.244; 97.674
471Wenger, Mazal; Bernstein, Joel
Cocrystal Design Gone Awry? A New Dimorphic Hydrate of Oxalic Acid
Molecular Pharmaceutics, 2007, 4, 355
1505189 CIFC26 H22 N4 O2P 1 21/c 113.223; 6.1971; 14.63
90; 113.661; 90
1098.1Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505190 CIFC19 H15 N3 OC 1 2/c 118.715; 7.228; 23.208
90; 90.478; 90
3139Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505191 CIFC26 H20 N4 O2P 1 21/n 116.5421; 7.5056; 18.709
90; 106.763; 90
2224.2Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505192 CIFC24 H18 N4 O2P 1 21/c 120.866; 7.437; 6.7662
90; 98.142; 90
1039.4Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505193 CIFC18 H14 N2 OP 1 21/c 19.906; 21.65; 7.59
90; 112.14; 90
1508Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505194 CIFC24 H18 N4 O2P 1 21/n 112.7871; 7.2838; 44.445
90; 90.895; 90
4139Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505195 CIFC18 H14 N2 OC 1 2/c 126.217; 7.481; 19.41
90; 128.31; 90
2987Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505196 CIFC24 H18 N4 O2P -13.8483; 8.755; 14.364
96.647; 94.498; 95.474
476.5Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505197 CIFC26 H22 N4 O2P 1 21/c 111.195; 7.335; 13.53
90; 99.465; 90
1095.9Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505198 CIFC19 H15 N3 OC 1 c 118.503; 7.5019; 21.971
90; 92.181; 90
3047.5Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505199 CIFC19 H15 N3 OP -17.616; 10.003; 22.497
87.342; 81.024; 69.737
1588.1Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505200 CIFC26 H20 N4 O2P 1 21/c 114.66; 4.11; 18.29
90; 90.74; 90
1101.9Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505201 CIFC24 H18 N4 O2C 1 2/c 139.87; 7.586; 6.915
90; 91.972; 90
2090Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505202 CIFC24 H18 N6 O3P -17.889; 8.156; 19.673
83.866; 85.627; 63.512
1125.9Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505203 CIFC18 H14 N4 O2P -19.171; 9.941; 10.265
95.674; 94.987; 114.784
836.9Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505204 CIFC30 H24 F4 N4 O4 SP -18.274; 10.172; 18.601
87.521; 78.256; 71.067
1449.4Bis, Joanna A.; Vishweshwar, Peddy; Weyna, David; Zaworotko, Michael J.
Hierarchy of Supramolecular Synthons: Persistent Hydroxyl···Pyridine Hydrogen Bonds in Cocrystals That Contain a Cyano Acceptor
Molecular Pharmaceutics, 2007, 4, 401
1505205 CIFC12 H10 N4 O5P 1 21/n 110.385; 7.2222; 16.3763
90; 93.686; 90
1225.72Babu, N. Jagadeesh; Reddy, L. Sreenivas; Nangia, Ashwini
Amide−N-Oxide Heterosynthon and Amide Dimer Homosynthon in Cocrystals of Carboxamide Drugs and PyridineN-Oxides
Molecular Pharmaceutics, 2007, 4, 417
1505206 CIFC16 H18 N4 O5P -18.4083; 9.8893; 10.6761
73.201; 79.022; 74.182
811.64Babu, N. Jagadeesh; Reddy, L. Sreenivas; Nangia, Ashwini
Amide−N-Oxide Heterosynthon and Amide Dimer Homosynthon in Cocrystals of Carboxamide Drugs and PyridineN-Oxides
Molecular Pharmaceutics, 2007, 4, 417
1505207 CIFC6 H6 N3 O4P 1 21/n 15.258; 6.478; 22.118
90; 95.795; 90
749.5Babu, N. Jagadeesh; Reddy, L. Sreenivas; Nangia, Ashwini
Amide−N-Oxide Heterosynthon and Amide Dimer Homosynthon in Cocrystals of Carboxamide Drugs and PyridineN-Oxides
Molecular Pharmaceutics, 2007, 4, 417
1505208 CIFC24 H18 N4 O8 S2P 1 21/n 16.5207; 14.0377; 13.1232
90; 104.28; 90
1164.12Babu, N. Jagadeesh; Reddy, L. Sreenivas; Nangia, Ashwini
Amide−N-Oxide Heterosynthon and Amide Dimer Homosynthon in Cocrystals of Carboxamide Drugs and PyridineN-Oxides
Molecular Pharmaceutics, 2007, 4, 417
1505209 CIFC13 H17 N3 O4P 1 21/c 17.2276; 19.5811; 9.9928
90; 98.136; 90
1399.99Babu, N. Jagadeesh; Reddy, L. Sreenivas; Nangia, Ashwini
Amide−N-Oxide Heterosynthon and Amide Dimer Homosynthon in Cocrystals of Carboxamide Drugs and PyridineN-Oxides
Molecular Pharmaceutics, 2007, 4, 417
1505210 CIFC20 H26 N4 O5P 1 21/c 18.2106; 23.9166; 20.6318
90; 96.67; 90
4024Babu, N. Jagadeesh; Reddy, L. Sreenivas; Nangia, Ashwini
Amide−N-Oxide Heterosynthon and Amide Dimer Homosynthon in Cocrystals of Carboxamide Drugs and PyridineN-Oxides
Molecular Pharmaceutics, 2007, 4, 417
1505211 CIFC24 H22 N4 O6P -15.692; 9.482; 10.751
69.893; 84.232; 84.969
541.2Babu, N. Jagadeesh; Reddy, L. Sreenivas; Nangia, Ashwini
Amide−N-Oxide Heterosynthon and Amide Dimer Homosynthon in Cocrystals of Carboxamide Drugs and PyridineN-Oxides
Molecular Pharmaceutics, 2007, 4, 417
1505212 CIFC9 H11 N2 O4P -16.409; 7.372; 11.064
96.127; 97.22; 105.35
494.7Babu, N. Jagadeesh; Reddy, L. Sreenivas; Nangia, Ashwini
Amide−N-Oxide Heterosynthon and Amide Dimer Homosynthon in Cocrystals of Carboxamide Drugs and PyridineN-Oxides
Molecular Pharmaceutics, 2007, 4, 417

Blue left arrow Blue left arrow First | Blue left arrow Previous 50 | of 85 | Next 50 Blue right arrow | Last Blue right arrow Blue right arrow | Display 5 20 50 100 200 300 500 1000 entries per page

Back to the search form
Your own data is not in the COD? Deposit it, thanks!